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ABSTRACT: Mycobacterium tuberculosis (Mtb) is the causative agent of
tuberculosis (TB) and has evolved an incredible ability to survive latently within
the human host for decades. The Mtb pathogen encodes for a low number of
ATP-binding cassette (ABC) importers for the acquisition of carbohydrates that
may reﬂect the nutrient poor environment within the host macrophages. Mtb
UgpB (Rv2833c) is the substrate binding domain of the UgpABCE transporter
that recognizes glycerophosphocholine (GPC), indicating that this transporter has
a role in recycling glycerophospholipid metabolites. By using a combination of
saturation transfer diﬀerence (STD) NMR and X-ray crystallography, we report
the structural analysis of Mtb UgpB complexed with GPC and have identiﬁed that
Mtb UgpB not only recognizes GPC but is also promiscuous for a broad range of
glycerophosphodiesters. Complementary biochemical analyses and site-directed
mutagenesis precisely deﬁne the molecular basis and speciﬁcity of glycerophos-
phodiester recognition. Our results provide critical insights into the structural and
functional role of the Mtb UgpB transporter and reveal that the speciﬁcity of this ABC-transporter is not limited to GPC,
therefore optimizing the ability of Mtb to scavenge scarce nutrients and essential glycerophospholipid metabolites via a single
transporter during intracellular infection.
Bacterial pathogens have evolved a wide range of strategiesto survive and thrive within their host environment. The
ability to assimilate nutrients is vital, and pathogens have
evolved diverse strategies to uptake and scavenge the scarce
energy sources that are available to them. In the context of
intracellular microbial infections, there is growing evidence
that in a nutrient limited environment the interplay between
the host and the pathogen is important. This is manifested
through the ability of bacterial pathogens to utilize discrete
nutrient sources with dedicated transport machinery for
import. Glycerophosphodiester metabolites that are released
by the action of phospholipases on host phospholipids
represent an important nutrient source for the supply of
carbon and phosphate.
Mycobacterium tuberculosis (Mtb) is a major human pathogen
and is now the leading cause of death from a single infectious
agent worldwide, resulting in more deaths each year than HIV
and malaria combined.1 Mtb is a highly evolved pathogen that
is able to persist and survive intracellularly within macrophages
for decades.2 However, the essential nutrients that are available
to Mtb within the stringent environment of the human host
and acquisition systems are poorly understood.3,4 Under-
standing the molecular mechanisms that enable Mtb to survive
within this niche environment and the nutrients that are
assimilated is critical to understand this major global pathogen
and for the development of new therapeutic approaches.
The sugars that are available within the nutrient-limited
macrophage environment are unknown; however, Mtb is
equipped with ﬁve putative importers of carbohydrate
substrates: four members of the ATP-binding cassette (ABC)
transporter family and one belonging to the major facilitator
superfamily.3,4 Until recently, the substrates for these trans-
porters were unresolved; however, recent studies have
demonstrated a role for the ABC-transporters in the recycling
of components from the complex Mtb cell wall. Trehalose is
recycled from the Mtb cell envelope glycolipid trehalose
monomycolate and taken up by the LpqY-SugABC-transporter,
which plays a critical role in the virulence of the Mtb
pathogen.5 The Mtb UspABC-transporter has been found to
recognize amino-sugars with a potential role in the uptake of
Mtb cell wall peptidoglycan fragments.6
The role of the UgpABCE ABC-transporter is less clear;
however, studies of its substrate binding domain Mtb UgpB
(Rv2833c) indicate its importance for Mtb survival and
pathogenesis, and in vivo Mtb UgpB has been found to be
upregulated during infection.7 Mtb UgpB has been shown to
bind the glycerophosphocholine (GPC) headgroup of the
membrane phospholipid phosphatidylcholine, and metabolo-
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mic proﬁling by NMR of intact lung tissue at various stages of
Mtb infection has revealed that the GPC metabolite increases
signiﬁcantly as infection progresses, with a concomitant
decrease in phosphatidylcholine.8 However, despite the
essential role of this Mtb transporter, the molecular
mechanisms that dictate how GPC is recognized and whether
other glycerophosphodiester metabolites are substrates for this
ABC-transporter are currently unknown. The only crystal
structure of Mtb UgpB is of the protein in an open
conformation without substrate bound (PDB 4MFI).9 Some
mechanistic understanding of substrate recognition can be
obtained from the crystal structure of a homologue from E. coli
with low sequence identity (25%) in complex with glycerol-3-
phosphate (G3P) (PDB 4AQ4).10 However, Mtb UgpB does
not bind G3P. Comparison of the closed G3P-bound E. coli
UgpB with the open Mtb UgpB in the absence of substrate
(PDB 4MFI) reveals notable diﬀerences in the binding sites of
these homologous proteins, indicating that these UgpB ABC-
transporters, belonging within the same structural classiﬁcation
(cluster D),11 have diverged to have diﬀerent substrate
speciﬁcities. This may reﬂect the nutritional requirements of
the speciﬁc organism within diﬀerent host environments and
also the ability of bacteria to produce G3P extracellularly
through the action of secreted glycerophosphodiesterases that
hydrolyze glycerophopshodiesters.12 Other microorganisms
that import GPC have evolved to use either permeases or
proton symporters that belong to the major facilitator
superfamily indicating that glycerophosphodiester uptake is
not limited to ABC-transporters.13,14 It is likely that the
divergence of transport systems for the import of glycer-
ophosphodiesters reﬂects the evolutionary divergence and
intracellular lifestyle of the pathogen and the metabolites
available within its niche environment.
In this study, we report a detailed functional and structural
characterization of the Mtb UgpB substrate binding domain of
the ABC-transporter using a combination of biochemical and
biophysical approaches. We report the ﬁrst crystal structure of
Mtb UgpB in complex with GPC and identify, in both solid
and solution state, the molecular determinants of binding and
critical features for glycerophosphodiester recognition. Struc-
ture guided mutagenesis has revealed the crucial role of
binding-site residues that underpin substrate binding and
function. Moreover, we show that Mtb UgpB has a broad
selectivity for glycerophosphodiesters, which highlights that
the Mtb UgpABCE transporter uptakes metabolites derived
from various glycerophospholipids. Thus, Mtb has evolved to
use a broad spectrum of nutrients via a single ABC-transporter
that enables it to adapt and assimilate essential nutrients during
intracellular infection.
■ RESULTS AND DISCUSSION
Production of Mtb UgpB. An N-terminal truncated Mtb
UgpB, corresponding to removal of residues 1−34 predicted to
form a trans-membrane anchor-helix, was cloned into the
pYUB1062 vector with a C-terminal hexa-histidine aﬃnity tag
and expressed in Mycobacterium smegmatis mc24517. Soluble
Mtb UgpB protein was obtained and puriﬁed to apparent
homogeneity using Co2+-aﬃnity, anion exchange, and size-
exclusion chromatography (Figure S1). The identity of the
Mtb UgpB protein was conﬁrmed by using in-gel trypsin
digestion and analysis of the peptides by mass spectrometry.
Co-Crystal Structure of Mtb UgpB with GPC. Initial
attempts to crystallize Mtb UgpB in the presence of GPC
routinely resulted in crystals of UgpB in an open conformation
with no ligand bound. Therefore, to overcome this, we
chemically modiﬁed the surface of Mtb UgpB through
reductive methylation, and this resulted in crystals of UgpB
in complex with GPC. The UgpB protein co-crystallized with
GPC with four molecules in the asymmetric unit. Phases for
the structure were determined by molecular replacement using
each of the two domains from the apo-structure of Mtb UgpB
(PDB 4MFI) as separate search models, and the structure was
reﬁned at a resolution of 2.3 Å and to a Rwork of 20.6% and Rfree
of 25.6%; see Table S1 for the data collection and reﬁnement
statistics. Structural superposition of each molecule of Mtb
UgpB using PDBeFOLD15 indicates that each molecule within
the asymmetric unit is equivalent, aligning with a rmsd of
0.35−0.44 Å for 394−395 residues. The crystal packing and
analysis of the packing interfaces using PDBePISA16 does not
suggest that Mtb UgpB forms dimers or higher oligomers and
is consistent with our analytical gel ﬁltration studies where the
protein behaves as a monomer in solution with an apparent
molecular weight of 44 kDa (Figure S1D). It is therefore likely
that the monomer is the biologically relevant unit, consistent
with substrate binding domains of other ABC-transporters.17,18
Overall Structure of the Mtb UgpB−GPC Complex.
Mtb UgpB comprises two α/β domains (Figure 1). Domain I
(residues 1−154 and 307−365) consists of a ﬁve-stranded β-
sheet surrounded by 11 α-helices and domain II (residues
155−306 and 366−436), of a four-stranded β-sheet enclosed
by 9 α-helices. The two domains, or globular lobes, are
connected via two ﬂexible hinges that are formed between
residues Arg152-Pro155 and Ala290-Ala307. Relative to the
apo-crystal structure, there is a 22° rotation of domain I
Figure 1. Crystal structure of Mtb UgpB. (A) Surface representation
of Mtb UgpB in complex with GPC. The two domains are
highlighted: domain I (brown) and domain II (green). The GPC
ligand is represented as spheres with dark gray carbon atoms. (B)
Cartoon representation of Mtb UgpB in complex with GPC
identifying the secondary structure elements. Domain I (brown)
and domain II (green). The two hinge regions are highlighted in blue.
The GPC ligand is represented as spheres with dark gray carbon
atoms. (C) Superposition of domain I of GPC Mtb UgpB cocomplex
(brown/green) with domain I of apo-Mtb UgpB (PDB 4MFI)
(magenta/orange). (D) Surface representation of the unliganded Mtb
UgpB (PDB 4MFI) with the two domains colored magenta (domain
I) and orange (domain II).
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relative to domain II about the interdomain screw axis with
three hinge/binding regions identiﬁed from DynDom
analysis19 (residues 152−153, 304−306, and 362−372
(Table S2)). This bending movement results in an almost 2-
fold reduction in the volume of the cavity from 1986 to 791 Å3,
as determined by CAVER,20 which is in-line with the “Venus
Fly-trap mechanism” for other substrate-binding proteins17,18
that close when the substrate is bound. Interdomain bridging
and stabilization of this closed conformation of the protein is
centered around Arg385, which forms interdomain hydrogen
bonds with Asp102 from domain I and Gln381 from domain
II. The individual domains of Mtb UgpB apo- and GPC
cocomplex structures align with rmsd values of 0.57 and 0.75 Å
for domains I and II, respectively (over 178 atoms, domain I;
over 216 atoms, domain II, PDBeFOLD16). In comparison,
superposition of Mtb UgpB apo- and GPC cocomplex
structures align with a rmsd of 2.2 Å (over 385 residues),
highlighting the importance of an interdomain conformational
change mechanism for substrate recognition by Mtb UgpB.
Figure 2. GPC binding site in Mtb UgpB. (A) Illustration showing GPC with dark gray carbon atoms and selected Mtb UgpB amino acid residues
in stick representation (colored brown for residues within domain I and green for residues with domain II). (B) Schematic diagram of the
interactions of Mtb UgpB with GPC. Dashed lines (black) represent hydrogen bonding, and the thick dotted line (red) represents hydrophobic
interactions
Figure 3. Comparison of Mtb UgpB with E. coli UgpB. (A) Superposition of the Mtb UgpB GPC complex structure (blue) with E. coli UgpB in
complex with G3P (PDB 4AQ4) (brown). Loop regions that diﬀer are highlighted in yellow and magenta. (B) Close-up illustration showing the
binding orientation of the GPC ligand and G3P ligand in stick representation (dark gray carbon atoms, GPC; cyan carbon atoms, G3P). (C) Close-
up of the overlay of the binding sites of GPC (Mtb) and G3P (E. coli). Selected residues are shown as sticks (Mtb, blue; E. coli, brown), and the font
is labeled in black (Mtb) and blue (E. coli). (D) Surface representation of the Mtb UgpB GPC binding pocket with the GPC ligand in stick
representation. (E) Surface representation of the E. coli UgpB G3P binding pocket in the same orientation as D with the G3P ligand in stick
representation.
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Ligand-Binding Site of Mtb UgpB.Well-deﬁned electron
density for the GPC ligand in all Mtb UgpB molecules within
the crystal unit was observed, enabling the GPC ligand to be
modeled in the Mtb UgpB binding site (Figure S2A). The
GPC ligand is found in an identical position and orientation in
each subunit (Figure S2B). Notably, the electrostatic surface
shows that GPC is buried in the prominent, acidic interface
that is formed between the two domains of UgpB and makes
contact with both. The GPC is precisely orientated within the
binding cleft such that the glycerol moiety is buried at the base
of the cavity, in close proximity to the ﬂexible-hinge region
centered around Arg385, while the choline moiety extends
outward towards the solvent exposed channel entrance (Figure
2).
The glycerol moiety is located between the side chains of
Leu205 and Trp208 from domain II (Figure 2). The ring
system of Trp208 lies approximately parallel to the C1, C2,
and 2-hydroxy group of the glycerol moiety enabling π-stacking
interactions, while Leu205 is orientated perpendicular to this
plane and provides additional stabilization. There is an
important network of hydrogen bonding interactions that
anchors GPC in the binding pocket. The side chain of Asp102,
from domain I, is orientated to enable direct hydrogen bonding
to both the 1- and 2-hydroxy groups of the glycerol moiety.
Two residues that comprise the ﬂexible-hinge linkages are able
to directly interact with GPC through the formation of
additional hydrogen bond interactions between the side chain
of Arg385 and the 1-hydroxy group and the backbone amide
nitrogen atom of Gly306 with the 2-hydroxy group,
respectively. The direct interaction of these ﬂexible-hinge
linkages with the GPC ligand may help to stabilize the UgpB−
GPC complex in the closed conformation. The phosphate
group of GPC is stabilized through hydrogen bond interactions
with the side chains of Tyr78 and Tyr345 (domain I), Ser153
(domain I), Ser272 (domain II), and the backbone amide of
Gly306. It is striking that there are no direct or charged
interactions between Mtb UgpB and the positively charged
choline moiety, though this moiety is well-deﬁned in the
electron density.
Comparison with the Binding Site of E. coli UgpB.
The comparison with UgpB from E. coli10 indicates that the
overall architecture of these two periplasmic binding proteins
in complex with substrate is similar, with a rmsd of 2.1 Å
(PDBeFold,15 394 target residues, 25% sequence identity
(Figure S3), PDB code 4AQ4), Figure 3. While Mtb was
crystallized with GPC, the E. coli protein was crystallized with
G3P, which we, as well as previous studies,10 show does not
bind to Mtb UgpB. It is interesting to note that the binding
mode of the G3P core of GPC resembles the situation found in
the E. coli UgpB−G3P complex,10 even though Mtb UgpB is
unable to bind or recognize this smaller G3P ligand (Figure
3B). However, while the substrate binding pocket of Mtb
UpgB resembles that of E. coli UgpB, there are several
important diﬀerences. Notably, there are substitutions of
critical residues involved in substrate binding. Leu205 is
speciﬁc to Mtb and is replaced by a larger indole side chain
from a tryptophan residue (Trp169) in E. coli UgpB. In
addition, Mtb UgpB Asp102 is replaced in E. coli UgpB by a
glutamic acid residue (Glu66) (Figure 3C). In this instance,
the diﬀerence in the length of these acidic side chains may
inﬂuence substrate selectivity between the diﬀerent organisms.
Intriguingly, while the interaction with an arginine residue is
conserved between Mtb and E. coli, the arginine residues in the
two proteins originate from diﬀerent regions of the protein,
indicating an evolutionary divergence of these substrate-
binding proteins. In addition, a narrowing of the E. coli
UgpB binding cleft results from two diﬀerent loop regions.
One loop region (Gly221−Asp230) in domain II of E. coli
UgpB linking α-helices 10 and 11 narrows the substrate
binding cavity as a result of a 5 Å translational shift. The
diﬀerence in position of a second loop comprised of residues
His8−Gly12 results in the translation of the ﬁrst α-helix of
E. coli UgpB (residues 12−30) located in domain I by
approximately 6 Å toward α-helix 11 of domain II, which
further narrows the E. coli UgpB substrate binding channel
(Figure 3D,E). The comparison of the region at the entrance
to the binding cleft reveals an expanded pocket for Mtb UgpB.
It is of interest to note that in chain B of Mtb UgpB we observe
an additional glycerol molecule located in this expanded
pocket that is within 4 Å of the choline moiety of GPC (Figure
S4). A glycerol molecule is also present in the E. coli UgpB−
G3P complex, though at a diﬀerent position, indicating that for
both proteins the binding pockets are larger than the
recognized GPC substrate.10 This may be functionally
signiﬁcant in substrate recognition and have an important
role in the accommodation and binding of alternative
phosphodiester substrates.
Solution Saturation Transfer Diﬀerence NMR of Mtb
UgpB with Glycerophosphocholine. Given the apparent
discrepancy between the lack of interactions formed between
the choline moiety and its importance in binding and given
that G3P lacking the choline moiety does not bind, we
Figure 4. STD NMR forMtb with GPC. (A) Experimental STD build up curves for the GPC/Mtb UgpB complex and the obtained epitope map of
GPC/Mtb UgpB. (B) STD values in the red bars were obtained with a 4 s saturation time, while in the blue bars, the CORCEMA-ST calculated
STD values from the 3D crystallographic structure of the Mtb UgpB/GPC complex obtained for the same saturation time are shown. RNOE factor,
0.25. (C) Diﬀerential epitope (DEEP)-STD factors showing the type of amino acid that the protons of the GPC ligand are orientated toward.
Protons orientated toward aliphatic residues are highlighted in blue, and protons orientated toward aromatic residues are highlighted in magenta.
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investigated binding in the solution state. We employed
saturation transfer diﬀerence (STD) NMR to obtain
quantitative maps of the ligand−protein complex in solution
(Figure 4).21 Binding was detected for GPC, and binding
epitope mapping was obtained and analyzed as described in the
Methods section.22 The STD NMR signals and the GPC
binding epitope and maps obtained are shown in Figure 4.
From the epitope map, the glycerol moiety of GPC is identiﬁed
as the main recognition element showing the highest STD
normalized values. In particular, the highest STD intensity
values were observed for the protons in positions 1 and 2
(H1G and H2G) of the glycerol moiety (Figure 4A), with
slightly lower intensity values for the protons in position 3
(H3G). The STD values decrease from the glycerol moiety to
the choline group, indicating that the ligand−protein contacts
are closer to the glycerol group than to choline. Intermediate
and low STD NMR intensity values were observed for the
protons in positions 1 and 2 (H1C and H2C), while low
intensity values were observed for the methyl groups from the
choline moiety. A quantitative comparison of the NMR
solution data with the X-ray structure of the complex was
carried out using CORCEMA-ST calculations23 as well as the
newly developed method DEEP-STD NMR,24 and the results
are summarized in Figure 4. An NOE R-factor25 of 0.25 was
obtained when comparing the CORCEMA-ST calculated STD
NMR intensities using the crystal structure with the
experimentally obtained solution data. This indicates a very
good agreement of the complex in the solution state with the
crystal structure. In order to probe for additional structural
information in the solution state, we then utilized diﬀerential
epitope mapping by STD NMR (DEEP-STD NMR). This
methodology allows us to gain information about the
orientation of the ligand within the architecture of the binding
site and indirectly gives us information about the type of amino
acids (aromatic, polar, or apolar residues) surrounding the
ligand in the bound state.26 The DEEP-STD NMR factors
clearly identiﬁed that the protons in position 3 of the glycerol
moiety of GPC are orientated toward aliphatic amino acids,
while the protons in position 1 in the choline moiety are
oriented toward aromatic residues (Figure 4C). On the basis of
the crystal structure of Mtb UgpB, these residues can be
mapped to Leu205, Tyr78, and Tyr345, respectively (Figure
2). Notably, our data shows a strong correlation for the
molecular determinants of GPC ligand binding toMtb UgpB in
both solution and the solid state.
Substrate Speciﬁcity of Mtb UgpB. To establish the
importance of both the polar headgroup and the glycerol
moiety for substrate recognition binding, we analyzed the
binding interactions of Mtb UgpB with G3P, the preferred
substrate of E. coli UgpB, and phosphocholine by thermal shift
analysis and microscale thermophoresis. In contrast to GPC,
no binding interactions were observed for these smaller
derivatives. Taken together with our structural studies, these
results indicate that, while the glycerol moiety is the main
recognition element for Mtb UgpB and there are minimal
interactions with the polar headgroup, the entire phospho-
diester moiety is critical for substrate recognition and binding.
The lack of recognition of G3P byMtb UgpB is consistent with
the intracellular location of two putative Mtb glycerophospho-
diesterase enzymes (GlpQ1, Rv3842c; GlpQ2, Rv03127c) that
are predicted to degrade glyercophosphodiesters to produce
G3P and the corresponding alcohol.27,28 In direct contrast,
E. coli secretes glycerophosphodiesterase enzymes to enable
the extracellular production of G3P, and this is consistent with
the ability of the periplasmic E. coli UgpB to recognize the G3P
metabolite.12
Our structural studies in both the solid and solution state
revealed that the GPC substrate interacts predominantly with
Mtb UgpB through interactions with the glycerol backbone.
The lack of speciﬁc interactions between the protein and the
polar choline headgroup located at the entrance of the
substrate binding pocket led us to speculate that Mtb UpgB
may recognize alternative glycerophosphodiester analogues. To
directly investigate the substrate speciﬁcity of Mtb UgpB, we
used microscale thermophoresis (MST) to analyze the binding
interactions of other phosphodiester products formed from the
lipolysis of membrane glycerophospholipids (Figure 5). From
the substrates tested in each case, we were able to detect
binding for GPC, glycerophosphoserine (GPS), glycerophos-
phoethanolamine (GPE), glycerophosphoinositol (GPI), and
glycerophosphoinositol-4-phosphate (GPI4P) (Table 1, Figure
6). The measured Kd value for GPC was consistent with
previous results obtained by isothermal titration calorimetry
(ITC).9 Notably, Mtb UgpB also binds and recognizes GPE,
GPS, GPI, and GPI4P glycerophosphodiesters with binding
aﬃnities in the micromolar range (Table 1) with a preference
for positively charged polar head groups. Together, this
suggests that Mtb has evolved to have a single ABC-transporter
to scavenge a range of glycerophosphodiesters within its
nutrient poor intracellular environment. The preference for
Figure 5. Structure of glycerophosphodiesters and derivatives probed in this study.
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GPC could suggest that, as phosphatidylcholine is the main
glycerophospholipid in human lung tissue,29 Mtb UgpB has
evolved to recognize the most abundant glycerophosphodiester
available within the host environment with the potential to
recognize and transport a spectrum of additional glycerophos-
phodiesters, depending on the growth conditions and nutrient
availability during intracellular infection that can subsequently
be catabolized by Mtb pathways that are involved in polar
headgroup recycling.27 Notably, these glycerophospholipids
are also major constituents of the Mtb cell envelope,30,31 and
further experiments are underway to elucidate whether the
glycerophosphodiesters are derived from host- or Mtb-lipids.
As a ﬁnal evaluation for potential substrate promiscuity, we
screened a panel of carbohydrates and amino acids using a
thermal shift assay and assessed the binding of putative ligands
that resulted in a change in the melting temperature (Tm) of
Mtb UgpB, which can be indicative of binding. In total, 37
potential substrates were probed, including trehalose, which is
known to be a substrate of the Mtb LpqY-SugABC ABC-
transporter,5 and we found that none of the ligands that were
screened inﬂuenced the melting temperature (Figure S5). It
appears that, although Mtb encodes for only ﬁve putative
carbohydrate importers, each transport system has a deﬁned
substrate preference. Interestingly, these data indicate that the
substrate binding pocket of Mtb UgpB can eﬃciently
accommodate glycerophosphodiesters, but it is not able to
recognize other carbohydrates or amino acids.
STD NMR of Mtb UgpB with GPI4P. Next, to validate
some of the MST-binding data, we used STD NMR
spectroscopy for a more in-depth investigation of GPI4P
binding to Mtb UgpB. Again, the glycerol moiety of GPI4P was
the main recognition element with close contacts to Mtb
UgpB. High STD NMR intensity values were also observed for
the H1 and H2 protons of the inositol ring with intermediate
STD NMR values for H3 and H4 protons and low values for
H5 and H6 protons (Figure 7A,B). This diﬀers from the
situation of the choline headgroup of GPC where instead low
STD intensities were observed. Furthermore, the DEEP-STD
NMR maps reveal a slight modiﬁcation in the binding
orientation of the glycerol tail of GPI4P compared to GPC
as protons in position 3 orientated toward aromatic residues
this time. To gain 3D structural insights about this interaction,
we carried out docking calculations using Autodock Vina32
followed by validation using CORCEMA-ST calculations. An
NOE R-factor of 0.31 was obtained by comparing the
CORCEMA-ST calculated STD intensities from the best
scored docked structure of GPIP4 bound toMtb UgpB and the
experimental STD values. This indicates a good agreement of
the proposed docking structure of the Mtb UgpB/GPIP4
complex with the experimental STD NMR data. From Figure
7, we can observe that the protons in position 3 (H3G) are
oriented toward the aromatic residues, which was also
determined from DEEP-STD factor analysis. Further, also
the protons of inositol−phosphate moiety are in line with the
observed orientation from DEEP-STD factor analysis. In fact,
protons H4I, H1G, and H2G are oriented toward aliphatic
residue Leu205, while protons H1I, H3G, H6I, and H5I are
oriented toward the aromatic residues Tyr78 and Tyr345,
validating the proposed model structure with the experimental
STD and DEEP-STD NMR data. These studies indicate that
the size and charge of the glycerophosphodiester headgroup
are critical in deﬁning substrate selectivity and the binding
orientation of the glycerol tail.
Activity of Sequence Variants. In order to complement
our structural studies in both the solution and solid state and
assess the signiﬁcance of individual amino acids that were
identiﬁed to be important in molecular recognition and
Table 1. Binding Data for Mtb UgpBa
enzyme substrate Kd (μM) reference
Mtb UgpB GPC 3.6 ± 0.5 this study
Mtb UgpB GPS 14.9 ± 1.6 this study
Mtb UgpB GPE 74.7 ± 13.9 this study
Mtb UgpB GPI 1053.2 ± 313.4 this study
Mtb UgpB GPI4P 289.8 ± 54.1 this study
Mtb UgpB G3P − this study
Mtb UgpB phosphocholine − this study
Mtb UgpB Y78A GPC − this study
Mtb UgpB Y78A GPS − this study
Mtb UgpB Y78A GPE − this study
Mtb UgpB D102A GPC − this study
Mtb UgpB D102A GPS − this study
Mtb UgpB D102A GPE − this study
Mtb UgpB Ser153Ala GPC 309.8 ± 56.1 this study
Mtb UgpB S153A GPS 102.5 ± 16.4 this study
Mtb UgpB S153A GPE − this study
Mtb UgpB L205A GPC 161.7 ± 15.9 this study
Mtb UgpB L205A GPE 1360 ± 210 this study
Mtb UgpB W208A GPC − this study
Mtb UgpB S272A GPC − this study
Mtb UgpB Y345A GPC − this study
Mtb UgpB R385A GPC − this study
Mtb UgpB GPC 27.3 ± 2.0 9
Mtb UgpB G3P − 9
Mtb UgpB maltose − 9
Mtb UgpB L205W GPC − 9
Mtb UgpB L205W G3P − 9
E. coli UgpB GPC 5.1 ± 0.3 10
E. coli UgpB G3P 0.68 ± 0.02 10
a(−) = no binding detected; standard deviations from at least three
independent experiments. GPC: glycerophosphocholine; GPS:
glycerophosphoserine; GPE: glycerophosphoethanolamine; GPI:
glycerophosphoinositol; GPI4P: glycerophosphoinositol-4-phosphate.
Figure 6. Binding aﬃnities for Mtb UgpB. Binding of (A) GPC, (B)
GPS, (C) GPE, and (D) GPI4P toMtb UgpB measured by microscale
thermophoresis (MST). FNorm (%) is the normalized ﬂuorescence
signal of the change in MST signal. Error bars represent standard
deviations from at least three independent experiments.
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binding, we introduced single point mutations in eight
individual residues that were suggested to interact with the
glycerophosphodiester ligands. In each case, we conﬁrmed that
the substituted alanine mutation was not detrimental to the
correct folding of the protein by circular dichroism spectros-
copy (Figure S6). MST was used to determine the binding
aﬃnities of the Mtb UpgB protein with GPC, and complete
abrogation of binding was observed when Tyr78, Asp102,
Trp208, Ser272, Tyr345, and Arg385 were individually
replaced by an alanine, conﬁrming the signiﬁcance of these
residues in substrate selectivity and the importance in binding
recognition. In contrast, binding of GPC was still observed
when Ser153 and Leu205 were replaced by alanine, with a
corresponding 85- and 45-fold reduction in the Kd values,
respectively (Table 1), indicating that while these two
individual residues are important for binding, they are not
critical. Failure of these single-residue mutants to completely
abolish binding reﬂects that multiple amino acids are involved
in the interaction with GPC, as observed from the crystal
structure. Previous studies that mutated Mtb UgpB Leu205 to
a tryptophan residue to mimic the situation found in E. coli
UgpB were detrimental for binding of GPC, indicating that the
bulky indole side chain cannot be tolerated in Mtb UgpB9 and
did not enable recognition of G3P. The distinct glycerophos-
phodiester recognition of Mtb UgpB compared with E. coli
UgpB indicates that the mycobacterial UgpB transporter has
evolved to have unique speciﬁcity and function that is distinct
from other UgpB proteins.
In conclusion, to date, the nutrient requirements of Mtb
during infection and the corresponding transport systems have
not been fully elucidated. The structural and functional
understanding of mycobacterial ABC-transporters that import
essential nutrients is an important step to understanding the
mechanisms that support intracellular survival. Importantly, we
have identiﬁed that the essential Mtb UgpABCE importer is
linked with glycerophosphodiester uptake with wide substrate
selectivity. For the ﬁrst time, we have established the molecular
determinants of the distinct substrate selectivity of the UgpB
substrate binding protein from the Mtb pathogen that has
important structural and functional diﬀerences with E. coli
UgpB. We therefore propose a new role for the Mtb UgpABCE
transporter in the uptake of glycerophosphodiesters generated
from the degradation of membrane phospholipids as a route to
scavenge scarce nutrients during intracellular infection.
■ METHODS
Procedures for cloning, protein expression, crystallization, X-ray data
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